TipRanks
Advertisement
Advertisement
Innate Pharma to Spotlight Oncology Pipeline at H.C. Wainwright Investor Conference
PremiumCompany AnnouncementsInnate Pharma to Spotlight Oncology Pipeline at H.C. Wainwright Investor Conference
16d ago
Innate Pharma Raises €30 Million in Private Share Placement to Fund Oncology Pipeline
Premium
Company Announcements
Innate Pharma Raises €30 Million in Private Share Placement to Fund Oncology Pipeline
30d ago
Innate Pharma price target raised to $9 from $8 at BTIG
Premium
The Fly
Innate Pharma price target raised to $9 from $8 at BTIG
1M ago
Innate Pharma upgraded to Outperform from Market Perform at Leerink
PremiumThe FlyInnate Pharma upgraded to Outperform from Market Perform at Leerink
1M ago
Innate Pharma price target raised to $7 from $5 at H.C. Wainwright
Premium
The Fly
Innate Pharma price target raised to $7 from $5 at H.C. Wainwright
1M ago
Innate Pharma, Sobi to enable initiation of the TELLOMAK-3 study
Premium
The Fly
Innate Pharma, Sobi to enable initiation of the TELLOMAK-3 study
1M ago
Innate Pharma completes enrollment in dose escalation of IPH4502 study
PremiumThe FlyInnate Pharma completes enrollment in dose escalation of IPH4502 study
2M ago
Innate Pharma Reports Voting Outcomes from 2026 Annual General Meeting
Premium
Company Announcements
Innate Pharma Reports Voting Outcomes from 2026 Annual General Meeting
4M ago
Innate Pharma to Court Investors at Jefferies Global Healthcare Conference 2026
Premium
Company Announcements
Innate Pharma to Court Investors at Jefferies Global Healthcare Conference 2026
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100